Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | CDC25B | P30305 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4432004 | 0.92 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL16542652 | 0.92 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL60500 | 0.92 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL15303583 | 0.92 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL15823842 | 0.92 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL12352190 | 0.92 | MEN1 (0.53) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL487775 | 0.88 | MEN1 (0.34) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL11759426 | 0.86 | MEN1 (0.47) | MEN1CYP3A4ALOX15KMT2ALMNA | |
| SCHEMBL17210474 | 0.81 | MEN1 (0.34) | MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL17210477 | 0.79 | MEN1 (0.37) | MEN1CYP3A4ALOX15KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114054091-B | Supported catalyst and preparation method and application thereof | 山东新和成药业有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-116462578-B | Method for synthesizing delta-methyl ketone by one-pot method | 万华化学集团股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-110860284-B | Supported catalyst and preparation method and application thereof | 浙江大学 | 2021-04-02 | — | — | CN | claimed |
| CN-110860284-A | Supported catalyst and preparation method and application thereof | 浙江大学 | 2020-03-06 | — | — | CN | claimed |
| US-20200070132-A1 | PdIn Alloy Catalyst, Method for Manufacturing PdIn Alloy Catalyst and Application Thereof | ZHEJIANG NHU COMPANY LTD. (CN) | 2020-03-05 | — | — | US | claimed |
| WO-2020042524-A1 | PDIN ALLOY CATALYST, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | 浙江新和成股份有限公司 | 2020-03-05 | — | — | WO | claimed |
| EP-2609063-B1 | PROCESS FOR THE MANUFACTURE OF 3,7-DIMETHYL-1-OCTEN-3-OL | DSM IP ASSETS BV (NL) | 2018-05-16 | — | — | EP | claimed |
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-12-05 | — | — | US | claimed |
| EP-1256560-A2 | Process for the preparation of higher alpha,beta-unsaturated alcohols | BASF AKTIENGESELLSCHAFT (DE) | 2002-11-13 | — | — | EP | claimed |
| US-20020161263-A1 | Process for the preparation of ketones | DEGUSSA AG (DE) | 2002-10-31 | — | — | US | claimed |
| US-6184420-B1 | REACTING ALLYL ALCOHOLS OR PROPARGYL ALCOHOLS WITH ISOPROPENYL ETHERS WITH THE FORMATION OF KETALS OF ACETONE AS A BYPRODUCT, THE ISOPROPENYL ETHERS BEING PREPARED BY REACTING KETALS OF ACETONE WITH PROPYNE OR ALLENE | BASF AKTIENGESELLSCHAFT (DE) | 2001-02-06 | — | — | US | claimed |
| CN-1217316-A | Preparation for unsaturated ketone | BASF AG (DE) | 1999-05-26 | — | — | CN | claimed |
| CN-114907200-B | Preparation of allenone using copper sulfate or its hydrate | DSM IP ASSETS B.V. (NL) | 2026-05-26 | — | — | CN | disclosed |
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2026-04-09 | — | — | US | disclosed |
| EP-4489592-B1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LTD (GB) | 2025-12-24 | — | — | EP | disclosed |
| US-20250255827-A1 | BIODEGRADABLE MICROCAPSULES AND A METHOD FOR THEIR PREPARATION | XAMPLA LIMITED (GB) | 2025-08-14 | — | — | US | disclosed |
| US-4784797-A | ALDEHYDE REACTED WITH DIAMINE FOLLOWED BY SALT FORMATION OR QUATERNIZATION | THE DOW CHEMICAL COMPANY (US) | 1988-11-15 | — | — | US | disclosed |
| US-4784796-A | REACTION OF UNSATURATED ALDEHYDE WITH DIAMINE, FURTHER REACTED WITH CARBOXYLIC ACID OR QUATERNIZATION | THE DOW CHEMICAL COMPANY (US) | 1988-11-15 | — | — | US | disclosed |
| US-4310705-A | Preparation of higher unsaturated ketones | BASF AKTIENGESELLSCHAFT (DE) | 1982-01-12 | — | — | US | disclosed |
| US-3978100-A | Allenic esters, process for preparation thereof and process for rearrangement thereof | KURARAY CO., LTD. (JA) | 1976-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260096991-A1 | BIODEGRADABLE MICROCAPSULES AND METHOD FOR THEIR PREPARATION | PCTP, CLK4, MTCL3 | MEN1 3342/4885CYP3A4 4797/4885ALOX15 4169/4885 |
| US-20020161263-A1 | Process for the preparation of ketones | ADH1C, ADH1A, AKR1C1 | MEN1 1701/4885CYP3A4 414/4885ALOX15 201/4885 |
| US-20020183565-A1 | Preparation of higher alpha, beta-unsaturated alcohols | ADH1C, CHKB, PDK3 | MEN1 3386/4885CYP3A4 575/4885ALOX15 1063/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.